United States · FDA National Drug Code directory
RETHYMIC
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72359-001_6b1c53ef-4ff9-46ff-96ad-b0cb5609ec17
- Product NDC
- 72359-001
- Form
- IMPLANT
- Composition / generic term
- allogenic thymocyte-depleted thymus tissue-agdc
- Labeler
- Sumitomo Pharma America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20211008
- Source listing expiry
- 20261231
Source-listed ingredients
- ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC — 22000 mm/1
These values do not establish equivalence or a dose recommendation.
Packages
- 11 CONTAINER in 1 BOX (72359-001-01) / 4 IMPLANT in 1 CONTAINER (72359-001-02) · 72359-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →